Workflow
Guangzhou Novaken Pharm Co., Ltd. - B(H0245) - OC Announcement - Appointment (Revised)
2026-01-06 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. 廣州新濟醫藥股份有限公司 Guangzhou Novaken Pharm Co., Ltd. (A joint stock company incorporated in the People's Republic of China with limited liability) WARNI ...
Silicon Magic Semiconductor Technology (Hangzhou) Co., Ltd.(H0291) - OC Announcement - Appointment
2026-01-06 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Silicon Magic Semiconductor Technology (Hangzhou) Co., Ltd.* 芯邁半導體技術(杭州)股份有限公司 (a joint stock company incorporated in the People's Republic of Chi ...
Buda Juice LLC(BUDA) - Prospectus(update)
2026-01-06 01:43
As filed with the Securities and Exchange Commission on January 5, 2026. Registration No. 333-289874 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 7 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BUDA JUICE, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2080 46-4069365 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer 4030 Black Gold Drive ...
NeuroBo Pharmaceuticals(NRBO) - Prospectus
2026-01-05 22:04
Table of Contents As filed with the Securities and Exchange Commission on January 5, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Graphic METAVIA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial (IRS Employer incorporation or organization) Classification Code Number) Identification Number) Delaware 2834 47-2389984 545 C ...
Jefferson Capital Inc(JCAP) - Prospectus
2026-01-05 21:13
Table of Contents As filed with the U.S. Securities and Exchange Commission on January 5, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Jefferson Capital, Inc. (Exact name of registrant as specified in its charter) Delaware 6153 33-1923926 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification N ...
Picpay(PICS) - Prospectus
2026-01-05 20:05
As filed with the Securities and Exchange Commission on January 5, 2026. Registration No. 333-______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ––––––––––––––––––––––––––––––––––– FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ––––––––––––––––––––––––––––––––––– Picpay Holdings Netherlands B.V.* (Exact Name of Registrant as Specified in its Charter) ––––––––––––––––––––––––––––––––––– The Netherlands 7389 N/A (State or other jurisdiction of incorporation or org ...
BioRay Biopharmaceutical Co., Ltd.(H0288) - Application Proof (1st submission)
2026-01-05 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of BioRay Biopharmaceutical Co., Ltd. 浙 江 博 銳 生 物 製 藥 股 份 有 限 公 司 (the "Company") (A joint stock company incorporated ...
Hangzhou Diagens Biotechnology Co., Ltd. - B(H0289) - OC Announcement - Appointment
2026-01-05 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Hangzhou Diagens Biotechnology Co., Ltd. 杭州德適生物科技股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liabili ...
BioRay Biopharmaceutical Co., Ltd.(H0288) - OC Announcement - Appointment
2026-01-05 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. BioRay Biopharmaceutical Co., Ltd. 浙 江 博 銳 生 物 製 藥 股 份 有 限 公 司 (a joint stock company incorporated in the People's Republic of China with limited ...
Hangzhou Diagens Biotechnology Co., Ltd. - B(H0289) - Application Proof (1st submission)
2026-01-05 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Hangzhou Diagens Biotechnology Co., Ltd. 杭州德適生物科技股份有限公司 (the "Company") (A joint stock company incorporated in the ...